Thermo Fisher Scientific INC Form 4 insider transactions

Thermo Fisher Scientific and related entities report the disposition of Science 37 Holdings common stock at $5.75 per share following a 1-for-20 reverse stock split.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on March 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc N. Casper, exercised stock options and sold shares of common stock on March 11 and 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Lisa P. Britt, a Senior VP and Chief HR Officer at Thermo Fisher Scientific, exercised stock options and sold shares of common stock on March 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on February 27 and 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, reported the disposal of 291.068 shares of common stock on February 28, 2024, to cover tax obligations.

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, disposed of shares to cover tax obligations arising from vesting of restricted stock units.

Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific, reported the disposal of 705.429 shares of common stock to cover tax obligations.

Stephen Williamson, Sr. VP and CFO of Thermo Fisher Scientific, reported a transaction involving common stock on February 28, 2024.

Lisa P. Britt, a Senior VP and Chief HR Officer at Thermo Fisher Scientific, reported a transaction involving common stock on February 28, 2024.

Executive Vice President & COO of Thermo Fisher Scientific, Michel Lagarde, reports the disposal of common stock to cover tax obligations.